BioPharm International-09-02-2011

Features

September 02, 2011

Inside the National Institutes of Health

Developing a quality agreement template for single-use systems.

Market considerations and new technologies must be recognized to achieve the full benefits of manufacturing prefilled syringes.

Features

September 02, 2011

An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.

The lower price of biosimilars will increase patient access to medicines and spur innovation.

Features

September 02, 2011

The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.

Biopharmaceutical Trends Report